Medex deal yields $800 million worth of possibilities
This article was originally published in Clinica
Medex is to expand its cardio-pulmonary business through the acquisition of Inhalation Plastics (IPI), a manufacturer and distributor of anaesthesia and respiratory care products. The move, which will enhance Medex' core range of critical care products for use in intensive care, anaesthesia and catheterisation/radiology departments, is estimated to increase its global market potential by over $800m, Medex says.
You may also be interested in...
Abbott reported almost 28% revenue growth in the fourth quarter led by the exploding demand for COVID-19 tests and continued success of its FreeStyle Libre continuous glucose monitor.
While representing a smaller population, the ACTIVATE-T trial targeted patients seen as having greater unmet need.
As a freshman member on the US House Energy and Commerce Committee, former St. Jude Medical exec Rep. Angie Craig can help shape future health care, cybersecurity bills.